Skip to main content
. 2015 Sep 22;10(9):e0138340. doi: 10.1371/journal.pone.0138340

Table 1. Baseline characteristics of patients with freshly diagnosed pulmonary tuberculosis in the four treatment groups.

Features Placebo (n = 72) PBA (n = 72) vitD3 (n = 72) PBA+vitD3 (n = 72)
Intention-to-treat group, n = 288
Gender (Males) (Number, %) 44(61%) 44(61%) 44(61%) 45(62·5%)
History of contacts (Number, %)
Male 10(22.7%) 12(27.3%) 9(20.5%) 12(26.7%)
Female 13(46.4%) 8(28.6%) 10(35.7%) 12(44.4%)
BCG given (Number, %)
Male 33(75.0%) 24(54.5%) 35(79.5%) 32(77.1%)
Female 13(46.4%) 20(71.4%) 20(71.4%) 21(77.8%)
Age, years (Mean±SD) 26.7±8.1 26.8±7.3 28.1±9.9 26.8±6.9
Weight, kg (Mean±SD)
Male 46.3±6.6 48.9±6.5 47.9±8.4 46.6±6.6
Female 39.8±7.8 37.0±5.7 38.4±7.6 39.8±7.8
Tuberculin skin test done 7(2.4%) 12(4.2%) 8(2.8%) 9(3.1%)
Duration of illness, days (Mean±SD)
Male 50.9±26.8 48.8±20.6 55.1±2 6.5 53.6±28.7
Female 51.9±23.5 53.6±19.9 51.9±26.5 47.2±22.9
ESR, mm 1st hr (Mean±SD) 60.2±34.9 56.9±32.5 54.0±31.1 56.8±33.2
Hb, gm/dl (Mean±SD) 11.6±1.6 11.5±1.7 11.3±1.9 11.7±1.8
WBC, 1x103/cmm (Mean±SD) 10.56±2.63 9.99±2.16 10.93±2.88 11.36±3.21
Per-protocol group, n = 249
Vitamin D status # (n = 64) (n = 58) (n = 62) (n = 65)
Vitamin D nmol/L 28.1±16.2 23.8±14.8 28.0±17.5 26.8±16.3
Deficient, <30 nmol/L 40(62.5%) 41(70.7%) 46(74.2%) 39(60.0%)
Insufficient, 30–50 nmol/L 19(29.7%) 13(22.4%) 8(12.9%) 20(30.8%)
Sufficient, >50 nmol/L 5(7.8%) 4(6.9%) 8(12.9) 6(9.2%)

Data is presented as mean ± standard deviation or number with percentage in parentheses. BCG, Bacillus Calmette–Guérin.; ESR, erythrocyte sedimentation rate; Hb, hemoglobin; WBC, white blood cells. History of contacts, BCG given and Tuberculin skin test done are dichotomous variable and age, weight, duration of illness, ESR, Hb, WBC and vitamin D status are continuous variable.